PhRMA CEO Succession Appears Set: Timing Not Yet Final
This article was originally published in The Pink Sheet Daily
Executive Summary
The Pharmaceutical Research & Manufacturers of America is understood to have finalized its plans to name retiring Rep. Billy Tauzin (R-La.) as its next CEO
You may also be interested in...
PhRMA Makes It Official: Rep. Tauzin Takes Over As CEO Jan. 3
Chief of Staff Simoneaux and Communications Director Johnson are expected to move with Tauzin to PhRMA. The Louisiana Republican's battle with intestinal cancer will allow him to discuss his personal stake in the future of the industry as its top spokesman.
PhRMA Makes It Official: Rep. Tauzin Takes Over As CEO Jan. 3
Chief of Staff Simoneaux and Communications Director Johnson are expected to move with Tauzin to PhRMA. The Louisiana Republican's battle with intestinal cancer will allow him to discuss his personal stake in the future of the industry as its top spokesman.
PhRMA CEO Selection Day Nears Now That Election Day Is Past
Trade association board is expected to finalize choice to succeed CEO Alan Holmer during Nov. 11-12 strategy session. Rep. Billy Tauzin (R-La.) is still viewed as the likely pick.